Related Experiment Videos

Microtubules in cardiac toxicity and disease

Daniel R Webster1

  • 1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Dan.Webster@ttuhsc.edu

Cardiovascular Toxicology
|September 25, 2002
PubMed

Insights

Microtubules (MTs) are vital cytoskeletal components in heart cells, influencing cardiac development and function. Understanding MTs is key to managing side effects of MT-disrupting drugs used in cancer therapy.

Area of Science:

  • Cell Biology
  • Cardiovascular Science
  • Cytoskeletal Dynamics

Background:

  • Microtubules (MTs) are essential cytoskeletal elements in all eukaryotic cells.
  • MTs are involved in critical cellular processes like division, transport, and motility.
  • MTs play significant roles in cardiac development and physiological function.

Purpose of the Study:

  • To review the current understanding of microtubule contributions to cardiac function.
  • To explore how MTs are affected in cardiac disease states.
  • To highlight the implications for therapeutic interventions targeting microtubules.

Main Methods:

  • Literature review of experimental results and hypotheses.
  • Analysis of studies on MT-disrupting agents and their cardiac effects.
  • Examination of research on MT alterations in cardiac hypertrophy.

Main Results:

  • MTs are crucial for sarcomere mechanics, beat rate, and molecular secretion in the heart.
  • Therapeutic agents like vincristine and paclitaxel disrupt MTs, impacting cardiac activity.
  • Cardiac diseases such as hypertrophy alter the microtubule cytoskeleton.

Conclusions:

  • A comprehensive understanding of MTs in cardiac cells is necessary.
  • Minimizing adverse cardiac effects of MT-disrupting drugs requires further research.
  • MTs are central to both normal heart function and cardiac disease pathogenesis.

Related Concept Videos